Effect of Shenfu Injection to Prehospital Cardiac Arrest

Randomized, controlled, multi-center Clinical Trial with a large sample on Effect of Shenfu Injection to Prehospital Cardiac Arrest

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12003169

Enrollment

Unknown

Registered

2012-10-17

Start date

2013-03-01

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac arrest

Interventions

Research group:Shenfu injection plus Routine treatment

Control:Routine treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with cardiac arrest; 2. Patients with cardiopulmonary resuscitation; 3. Aged betwee 18-75 years old, male or female

Exclusion criteria

Exclusion criteria: 1. Patients who are sentenced to death by doctors or whose relatives chose do-not-resuscitate(DNR); 2. Patients have the obvious inability characteristics, such as rigor mortis, corruption; 3. Terminal stage of diseases (life time is less than 6 weeks or DNR status); 4. Cardiac arrest because of bleeding, such as aortic aneurysm rupture, massive hemorrhage of gastrointestinal tract.

Design outcomes

Primary

Measure	Time frame
admission survival rate;	—

Secondary

Measure	Time frame
the rate of ROSC;times of defibrillation;rate of survival to hospital discharge;CPC score;GCS score;	—

Countries

China

Contacts

Public ContactLi Chunsheng

Beijing Chaoyang Hospital

Lcscyyy@sohu.com+86 13681392380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026